Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today ...

Dr. Xie Fangmin, founder, chairman, and CEO of Fangzhou, remarked: “This launch is not simply a product milestone, but a strategic inflection point. XS LLM provides the technical foundation to embed ...